Ukraine Sees 72% Surge in Antidepressant Demand as Treatment Preferences Shift.

Antidepressant Demand in Ukraine

According to TSN.ua: Between 2023 and 2025, demand for antidepressants in Ukraine surged by 72%, a dramatic increase that coincides with declining interest in other psychotropic medications. This sharp rise in antidepressant demand stands in stark contrast to falling interest in nootropics, sedatives, and sleeping pills. On an annual basis, antidepressant demand grew by 25%, with a particularly sharp 46% increase in 2024 compared to the previous year.

Shifts in Demand for Psychotropic Drugs

Key changes across drug categories reveal a significant shift in patient and prescriber behavior. Demand for nootropics fell by 30% compared to 2024 levels. Similarly, demand for sedatives decreased by 29%, while interest in sleeping pills dropped by 31%. In 2025, demand for iron supplements rose by 21.7%, whereas antidepressant demand for the same year grew by approximately 25% year-on-year. This trend reflects a broader, global move towards more targeted mental health treatments, though the scale of change in Ukraine is particularly pronounced.

• Demand for sleeping pills has decreased by nearly 40%
• Tranquilizer demand has fallen by roughly 35% compared to 2024
• Declining demand is also observed for sedatives and nootropics, which have each lost about 30% of their market
• Demand for antipsychotics (neuroleptics) has decreased by 10%
• Medications supporting central nervous system function have seen a decline of 15-18%

'This is an encouraging signal: we are seeing people opt more often for systemic treatment rather than one-off solutions.' Anton Avrynskyi, Mental Health Expert

The rising demand for antidepressants in Ukraine may be linked to greater public awareness of mental health importance and a recognized need for more comprehensive approaches to treating depression. Amid ongoing challenges like war and economic hardship, more individuals are seeking effective, long-term treatment methods, which could influence the nation's overall mental health landscape. The declining interest in other psychotropic drugs suggests a potential shift in treatment paradigms, with a new focus on systematic and sustained solutions over temporary symptomatic relief.